Glycopyrrolate USP (Powder) For Compounding (API)

Glycopyrrolate USP is an active pharmaceutical ingredient (API) that is used in the treatment of excessive sweating (hyperhidrosis) and severe drooling caused by certain medical conditions such as cerebral palsy or Parkinson's disease. It works by decreasing the activity of sweat glands and saliva-producing glands, thereby reducing sweating and drooling. Glycopyrrolate USP belongs to a class of medications called anticholinergics and is available in various forms, including tablets, injections, and topical formulations. It is also used off-label to treat other conditions such as irritable bowel syndrome and bladder spasms.

Glycopyrrolate USP (powder) for compounding is a medication commonly used by pharmacists to prepare topical or injectable formulations for patients with certain medical conditions. Glycopyrrolate is a synthetic anticholinergic medication that is commonly used to reduce secretions and saliva production. It is often used to help manage excessive sweating (hyperhidrosis), drooling, or excess saliva production caused by medical conditions such as Parkinson's disease, ulcers, or chronic obstructive pulmonary disease (COPD). In compounding, glycopyrrolate may be used to create custom formulations such as topical gels, creams, or injectable solutions based on a patient's unique needs and preferences. However, it should only be used under the supervision and direction of a healthcare provider